Breast cancer

• ITP BLOCK FOR MINOR BREAST CANCER SURGERY Not authorised
  2022-501312-34-00 6
• Tumour heterogeneity studies based on dedicated breast PET using proliferation radiotracers: early detection of the treatment response. Pending
  2024-512152-38-00 9
• A phase I study of [68Ga]Ga-DWJ155 in patients with advanced breast and NSCLC cancers Pending
  2024-517746-34-00 1 "Advanced breast cancer and advanced NSCLC"
• Study of Antibiotic Combinations in Early Breast Cancer Pending
  2024-517993-94-00 4 "Breast Cancer"
• A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies Pending
  2024-518326-32-00 7 "Patients with advanced solid malignancies that have progress"
• A Study to Determine the Effectiveness of a Test Drug ([68Ga]BED003) for the Detection of Pancreatic, Colorectal, Gastric, Breast and Ovaria … Pending
  2025-521983-36-00 4 "Colorectal cancer (CRC), gastric cancer (GC), pancreatic duc"
• PHASE IB/II STUDY TO EVALUATE SAFETY AND PRELIMINARY EFFICACY OF ZANIDATAMAB IN COMBINATION WITH TUCATINIB AND CHEMOTHERAPY (CAPECITABINE OR … Pending
  2025-524613-89-00 9 "HER2 positive advanced breast cancer"
• Adjuvant Dynamic marker - Adjusted Personalized Therapy comparing adjuvant Elacestrant with standard endocrine treatment in genomically and/ … Recruiting
  2025-522484-15-00 5 2026-04-27 "ER+/HER2- early breast cancer"
• A Phase 2, randomized, multicenter, open-label neoadjuvant study evaluating zanidatamab in combination with chemotherapy in participants wit … Recruiting
  2025-523204-68-00 4 2026-03-25 "HER2-positive breast cancer"
• ROSETTA Breast-01: The effects and safety of pumitamig in patients with triple-negative breast cancer Recruiting
  2025-521884-12-00 5 2026-03-19 "First line triple-negative breast cancer (TNBC)"
• Preservation of Fertility by Ovarian Stimulation Associated With Tamoxifen, Prior Chemotherapy for Breast Cancer (PRESAGE) Recruiting
  2024-516282-37-00 4 2025-02-18
• A Clinical Trial to Assess a New Anti-Cancer Treatment (called DSB2455) Given On Its Own in Patients with Advanced Malignancies Recruiting
  2023-508805-26-00 1 2024-10-23 "patients with active brain metastases, where the primary tum"
• Improving the empowerment in patients with severe breast fibrosis radio-induced treated by Pravastatin : benefit of e-PROs (electronic « Pat … Recruiting
  2024-515342-16-00 4 2024-09-05 "Patients with severe and radio-induced breast fibrosis after"
• A randomized, open-label, phase II trial comparing neoadjuvant endocrine therapy in combination with trastuzumab, pertuzumab +/- the PI3K in … Recruiting
  2022-501152-28-00 4 2022-12-21 "Breast Cancer"
• A Phase 2 study of zanidatamab in patients with HER2-expressing tumors Recruiting
  2024-516551-41-00 4 2026-03-06 "Patients with HER2-expressing solid tumors"
• A clinical study to find the optimal dose of an investigational treatment called BNT323 when used in combination with another investigationa … Recruiting
  2024-517979-20-00 9 2026-03-04 "Advanced Breast Cancer Metastatic Breast Cancer"
• To compare the Safety and activity of GDC-4198 Alone and in Combination with Giredestrant against Abemaciclib and Giredestrant in Participan … Recruiting
  2025-521128-31-00 9 2025-12-18 "Locally Advanced or Metastatic Estrogen Receptor-Positive, h"
• A study to investigate the safety and efficacy of ONA-255 in participants with advanced cancer Recruiting
  2025-522233-62-00 7 2025-12-12 "Advanced cancer; breast cancer; metastatic gastric / gastroe"
• A clinical study to evaluate the safety, efficacy, and impact on quality of life of capivasertib alongside routine endocrine treatment in pa … Recruiting
  2024-511392-15-00 5 2025-11-20 "HR+/HER2- advanced breast cancer"
• TYPER Recruiting
  2024-520290-12-00 6 2025-11-04 "Hormone receptor–positive (HRpos)/human epidermal growth fac"
• A Phase 1/2, Multicenter, Open Label, Dose Escalation and Dose Expansion Study of JK06, a 5T4 Antibody Drug Conjugate, in Patients with Unre … Recruiting
  2024-512421-92-00 7 2025-10-14 "Unresectable, Locally Advanced or Metastatic Cancer"
• Long-term follow-up of patients treated with GD2IL18CART Recruiting
  2025-521497-34-00 1 2025-10-06 "Neuroblastoma"
• HER2-Targeting Site-Specific Labelled 89Zr-Trastuzumab PET Imaging of Patients with Cancer Recruiting
  2024-516786-37-00 1 2025-09-22 "Patients with breast cancer, gastroesophageal adenocarcinoma"
• A Phase 1 Open-label Study to Evaluate the Safety and Efficacy of MK‑8294 Monotherapy in Advanced Solid Tumors Recruiting
  2024-516870-31-00 1 2025-07-11 "Endometrial Carcinoma"

Showing 1–24 of 77 trials